doxylamine (Nastech)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namedoxylamine (Nastech)
Drug Alias Namedoxylamine
ClassificationSmall molecules
Mechanisms of ActionHistamine receptor antagonistsMuscarinic acetylcholine receptor antagonists
TargetsHistamine receptorMuscarinic acetylcholine receptor
Therapy Area/IndicationsSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAdhera Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSleep Initiation and Maintenance Disorders

Other Information

ATC CodeN/A
Related LinksN/A